{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T03:57:35Z","timestamp":1782964655871,"version":"3.54.5"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.jneuroim.2023.578129","type":"journal-article","created":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T00:53:09Z","timestamp":1686617589000},"page":"578129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Thymoma patients with or without myasthenia gravis have increased Th17 cells, IL-17 production and ICOS expression"],"prefix":"10.1016","volume":"381","author":[{"given":"Merve","family":"Cebi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arman","family":"Cakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eren","family":"Erdogdu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hacer","family":"Durmus-Tekce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulcin","family":"Yegen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berker","family":"Ozkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yesim","family":"Parman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guher","family":"Saruhan-Direskeneli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2023.578129_bb0005","first-page":"8","article-title":"Immune skew of circulating follicular helper T cells associates with myasthenia gravis severity","author":"Ashida","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.jneuroim.2023.578129_bb0010","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.autrev.2015.09.005","article-title":"Thymoma associated with autoimmune diseases: 85 cases and literature review","volume":"15","author":"Bernard","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jneuroim.2023.578129_bb0015","first-page":"4","article-title":"PD-1(hi)CXCR5(\u2212) T peripheral helper cells promote B cell responses in lupus via MAF and IL-21","author":"Bocharnikov","year":"2019","journal-title":"JCI Insight."},{"key":"10.1016\/j.jneuroim.2023.578129_bb0020","first-page":"482","article-title":"Antibodies to acetylcholine receptors, potassium channels, and titin in a patient with thymoma, myasthenia gravis, and limbic encephalitis","volume":"46","author":"Buckley","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2023.578129_bb0025","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.4049\/jimmunol.1501339","article-title":"Autoreactive T cells from patients with myasthenia gravis are characterized by elevated IL-17, IFN-gamma, and GM-CSF and diminished IL-10 production","volume":"196","author":"Cao","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2023.578129_bb0030","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3389\/fimmu.2020.00809","article-title":"CD4(+) T cells of myasthenia gravis patients are characterized by increased IL-21, IL-4, and IL-17A productions and higher presence of PD-1 and ICOS","volume":"11","author":"Cebi","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2023.578129_bb0035","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.molimm.2021.02.011","article-title":"Imbalance of Th17 and Tregs in thymoma may be a pathological mechanism of myasthenia gravis","volume":"133","author":"Chen","year":"2021","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jneuroim.2023.578129_bb0040","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/ana.20577","article-title":"A CTLA4high genotype is associated with myasthenia gravis in thymoma patients","volume":"58","author":"Chuang","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2023.578129_bb0045","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev-immunol-031210-101400","article-title":"Follicular helper CD4 T cells (TFH)","volume":"29","author":"Crotty","year":"2011","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2023.578129_bb0050","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1007\/s00125-019-4936-8","article-title":"Circulating CXCR5(\u2212)PD-1(hi) peripheral T helper cells are associated with progression to type 1 diabetes","volume":"62","author":"Ekman","year":"2019","journal-title":"Diabetologia."},{"key":"10.1016\/j.jneuroim.2023.578129_bb0055","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/art.41913","article-title":"Effect of clonally expanded PD-1(high) CXCR5-CD4+ peripheral T helper cells on B cell differentiation in the joints of patients with antinuclear antibody-positive juvenile idiopathic arthritis","volume":"74","author":"Fischer","year":"2022","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jneuroim.2023.578129_bb0060","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1093\/rheumatology\/kez169","article-title":"Two populations of circulating PD-1hiCD4 T cells with distinct B cell helping capacity are elevated in early rheumatoid arthritis","volume":"58","author":"Fortea-Gordo","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jneuroim.2023.578129_bb0065","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","article-title":"Myasthenia gravis: subgroup classification and therapeutic strategies","volume":"14","author":"Gilhus","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2023.578129_bb0070","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/ni1254","article-title":"Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages","volume":"6","author":"Harrington","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jneuroim.2023.578129_bb0075","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jns.2015.08.029","article-title":"Two-year outcome of thymectomy with or without immunosuppressive treatment in nonthymomatous myasthenia gravis and its effect on regulatory T cells","volume":"358","author":"Jakubikova","year":"2015","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2023.578129_bb0080","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.revmed.2017.03.003","article-title":"Thymoma and autoimmune diseases","volume":"39","author":"Jamilloux","year":"2018","journal-title":"Rev. Med. Interne"},{"key":"10.1016\/j.jneuroim.2023.578129_bb0085","first-page":"7","article-title":"Regulators of Tfh cell differentiation","author":"Jogdand","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2023.578129_bb0090","doi-asserted-by":"crossref","first-page":"rky043","DOI":"10.1093\/rap\/rky043","article-title":"Circulating PD-1(+)CXCR5(\u2212)CD4(+) T cells underlying the immunological mechanisms of IgG4-related disease","volume":"2","author":"Kamekura","year":"2018","journal-title":"Rheumatol. Adv. Pract."},{"key":"10.1016\/j.jneuroim.2023.578129_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2019.102337","article-title":"Risk factors associated with myasthenia gravis in thymoma patients: the potential role of thymic germinal centers","volume":"106","author":"Lefeuvre","year":"2020","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jneuroim.2023.578129_bb0100","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.imlet.2021.03.001","article-title":"Increased circulating PD-1(hi)CXCR5- peripheral helper T cells are associated with disease severity of active ulcerative colitis patients","volume":"233","author":"Long","year":"2021","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.jneuroim.2023.578129_bb0105","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jneuroim.2012.12.001","article-title":"Expansion of circulating counterparts of follicular helper T cells in patients with myasthenia gravis","volume":"256","author":"Luo","year":"2013","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2023.578129_bb0110","first-page":"1861","article-title":"Expanded circulating peripheral helper T cells in systemic lupus erythematosus: association with disease activity and B cell differentiation","volume":"58","author":"Makiyama","year":"2019","journal-title":"Rheumatology."},{"key":"10.1016\/j.jneuroim.2023.578129_bb0115","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1196\/annals.1254.025","article-title":"The role of thymomas in the development of myasthenia gravis","volume":"998","author":"Marx","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2023.578129_bb0120","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jneuroim.2010.03.016","article-title":"Clinical implication of peripheral CD4+CD25+ regulatory T cells and Th17 cells in myasthenia gravis patients","volume":"225","author":"Masuda","year":"2010","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2023.578129_bb0125","first-page":"354","article-title":"Thymectomy improves outcomes in myasthenia gravis, trial shows","author":"Mayor","year":"2016","journal-title":"Br. Med. J."},{"key":"10.1016\/j.jneuroim.2023.578129_bb0130","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/imm.13124","article-title":"Biological and clinical significance of T helper 17 cell plasticity","volume":"158","author":"Mazzoni","year":"2019","journal-title":"Immunology."},{"key":"10.1016\/j.jneuroim.2023.578129_bb0135","doi-asserted-by":"crossref","first-page":"5123","DOI":"10.4049\/jimmunol.1501463","article-title":"IL-21 and IL-4 collaborate to shape T-dependent antibody responses","volume":"195","author":"McGuire","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2023.578129_bb0140","doi-asserted-by":"crossref","first-page":"55ra78","DOI":"10.1126\/scitranslmed.3000448","article-title":"The inducible costimulator (ICOS) is critical for the development of human T(H)17 cells","volume":"2","author":"Paulos","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jneuroim.2023.578129_bb0145","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature20810","article-title":"Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis","volume":"542","author":"Rao","year":"2017","journal-title":"Nature."},{"key":"10.1016\/j.jneuroim.2023.578129_bb0150","article-title":"Thymoma in myasthenia gravis: from diagnosis to treatment","volume":"2011","author":"Romi","year":"2011","journal-title":"Autoimmune Dis."},{"key":"10.1016\/j.jneuroim.2023.578129_bb0155","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.4049\/jimmunol.2000783","article-title":"Autoreactivity of peripheral helper T cells in the joints of rheumatoid arthritis","volume":"206","author":"Sakuragi","year":"2021","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2023.578129_bb0160","doi-asserted-by":"crossref","first-page":"314","DOI":"10.21037\/jtd.2016.03.03","article-title":"Increased frequency of thymic T follicular helper cells in myasthenia gravis patients with thymoma","volume":"8","author":"Song","year":"2016","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.jneuroim.2023.578129_bb0165","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jneuroim.2005.10.001","article-title":"Altered expression of Th1-type chemokine receptor CXCR3 on CD4+ T cells in myasthenia gravis patients","volume":"172","author":"Suzuki","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2023.578129_bb0170","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jaut.2018.11.005","article-title":"Il-23\/Th17 cell pathway: a promising target to alleviate thymic inflammation maintenance in myasthenia gravis","volume":"98","author":"Villegas","year":"2019","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jneuroim.2023.578129_bb0175","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1365-3083.2012.02703.x","article-title":"T helper type 17 cells expand in patients with myasthenia-associated thymoma","volume":"76","author":"Wang","year":"2012","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.jneuroim.2023.578129_bb0180","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1056\/NEJMoa1602489","article-title":"Randomized trial of Thymectomy in myasthenia gravis","volume":"375","author":"Wolfe","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2023.578129_bb0185","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.cyto.2015.06.011","article-title":"Elevated plasma interleukin-17A in a subgroup of myasthenia gravis patients","volume":"78","author":"Xie","year":"2016","journal-title":"Cytokine."},{"key":"10.1016\/j.jneuroim.2023.578129_bb0190","doi-asserted-by":"crossref","first-page":"664","DOI":"10.3389\/fimmu.2020.00664","article-title":"Thymoma associated myasthenia gravis (TAMG): differential expression of functional pathways in relation to MG status in different Thymoma Histotypes","volume":"11","author":"Yamada","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2023.578129_bb0195","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1007\/s10072-017-3009-3","article-title":"High frequencies of circulating Tfh-Th17 cells in myasthenia gravis patients","volume":"38","author":"Yang","year":"2017","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2023.578129_bb0200","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.molimm.2020.09.007","article-title":"Expanded circulating peripheral helper T cells in primary biliary cholangitis: Tph cells in PBC","volume":"131","author":"Yong","year":"2021","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jneuroim.2023.578129_bb0205","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/s41423-020-00529-z","article-title":"Shared and distinct roles of T peripheral helper and T follicular helper cells in human diseases","volume":"18","author":"Yoshitomi","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.jneuroim.2023.578129_bb0210","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.expneurol.2014.01.024","article-title":"Thymic TFH cells involved in the pathogenesis of myasthenia gravis with thymoma","volume":"254","author":"Zhang","year":"2014","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.jneuroim.2023.578129_bb0215","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.4049\/jimmunol.1500725","article-title":"Augmentation of circulating follicular helper T cells and their impact on autoreactive B cells in myasthenia gravis","volume":"197","author":"Zhang","year":"2016","journal-title":"J. Immunol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572823001157?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572823001157?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T11:37:06Z","timestamp":1736336226000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572823001157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":43,"alternative-id":["S0165572823001157"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2023.578129","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thymoma patients with or without myasthenia gravis have increased Th17 cells, IL-17 production and ICOS expression","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2023.578129","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"578129"}}